Top 5 stories on injectable HIV treatment and PrEP from CROI 2024
Long-acting injectables can be a good option for people with adherence challenges
Long-acting injectables may be better than daily pills for people with adherence challenges
Poor design makes it a battle to get young children with HIV to take their medicine
DoxyPEP did not reduce STIs among women, probably due to low adherence
Oral PrEP can work just as well for women as men, modelling studies conclude
Is on-demand PrEP too demanding? Australian men’s experiences
Competing priorities impact HIV treatment adherence for South Africans with low incomes
Top 5 HIV treatment stories from IAS 2023
